Hengli Petrochemical Co Ltd (600346)
Shanghai Stock Exchange · China · prices in CNY · close of 20 Oct 2026
Key indicators
| Last close | CNY 15.50 |
|---|---|
| 52-week range | 14.76 – 27.26 |
| Return, 1 month / 3 months | −10.2% / +1.7% |
| Return, 1 year / 3 years | −8.7% / +7.4% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 48.9% |
| Worst drawdown (1 year) | -43.9% |
| Average daily value traded | 580.64M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hengli Petrochemical is a Chinese petrochemical producer based in Dalian. It makes purified terephthalic acid, ethylene glycol and polyester filament yarn, and it operates an integrated refining and petrochemical complex that turns crude oil into chemical intermediates and fibres. Its customers are textile, packaging and chemical manufacturers that use these materials as inputs for their own production. The company serves industrial markets in China and abroad.
The shares are listed on the Shanghai Stock Exchange in China under the code 600346, and the price on this page is in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hengli Petrochemical Co Ltd (600346) trades on the Shanghai Stock Exchange in China. It last closed at CNY 15.50 on 20 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 1,207 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.7% and over the last three months it rose 1.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 28 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -23.0% | ||
| From 52-week high | -42.0% | ||
| Momentum | 50 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 1.7% | ||
| 6-month return | -29.9% | ||
| 12-month return, skipping the last month | 1.8% | ||
| Stability (higher is calmer) | 46 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 48.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -43.9% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 580.64M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −1.1% |
|---|---|
| 1 month | −10.2% |
| 3 months | +1.7% |
| 6 months | −29.9% |
| 1 year | −8.7% |
| 3 years | +7.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 17.39 / 20.14 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.61 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Jun 2022 | CNY 1.0100 |
| 31 May 2021 | CNY 0.7700 |
| 18 Jun 2020 | CNY 0.4000 |
| 27 Jun 2019 | CNY 0.4200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.